Basic Information
Hyasynth Bio uses traditional and modern biological technologies, combined with computational analysis, to develop current drugs for almost all known human diseases on the market.Hyasynth Bio's expertise lies in utilizing a rapid and scalable platform based on engineered microorganisms (Better Cannabinoids technology platform) to achieve scalable, low-cost production of THC, CBD, CBG, and rare cannabinoids.
Hyasynth Biologicals Inc.
Montreal,Quebec,Canada
15~50 people
May 01, 2014
info@hyasynthbio.com

